Skip to main content
OpenTrials

Clinical trial condition

Antisynthetase Syndrome

Explore clinical trials studying Antisynthetase Syndrome. Study availability and eligibility vary by location and protocol.

10 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Antisynthetase Syndrome trial results

Recruiting

Descartes-08 in Autoantibody Myositis

NCT07391605

Conditions
Antisynthetase Syndrome, Antisynthetase syndrome, Muscular Diseases, +4 more
Locations
  • University of California, Irvine Orange, California, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • National Neuromuscular Research Institute Austin, Texas, United States
View Trial Details
Enrolling by invitation

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

NCT05979441

Conditions
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Antisynthetase syndrome, +11 more
Locations
  • Neuromuscular Clinical and Research Center - Neurology Phoenix, Arizona, United States
  • Attune Health Research, Inc Beverly Hills, California, United States
  • UCI Health - ALS and Neuromuscular Center - Neurology Orange, California, United States
  • UCSF Health - ALS and Neurodegenerative Disease Center - Dermatology San Francisco, California, United States
View all 92 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

NCT05523167

Conditions
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Antisynthetase syndrome, +11 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • HonorHealth Neurology - Bob Bove Neuroscience Institute - Neurology Scottsdale, Arizona, United States
  • Attune Health Research, Inc Beverly Hills, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 202 locations
View Trial Details

Related conditions